(Q52425426)

1 May 2018

title

The morality and ethics governing CRISPR-Cas9 patents in China. (English)

1 reference

1 May 2018

0 references

0 references

0 references

Yaojin Peng

1

1 reference

1 May 2018

publication date

1 June 2016

1 reference

1 May 2018

published in

Nature Biotechnology

1 reference

1 May 2018

volume

34

1 reference

1 May 2018

issue

6

1 reference

1 May 2018

page(s)

616-618

1 reference

1 May 2018

https://scigraph.springernature.com/pub.10.1038/nbt.3590

exact match

0 references

cites work

Does CRISPR-Cas open new possibilities for patents or present a moral maze?

1 reference

CRISPR germline engineering--the community speaks

21 January 2018

1 reference

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

21 January 2018

1 reference

CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III

21 January 2018

1 reference

The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli

21 January 2018

1 reference

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

21 January 2018

1 reference

Multiplex genome engineering using CRISPR/Cas systems

21 January 2018

1 reference

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes

21 January 2018

1 reference

The scope of patent protection for gene technology in China

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27281418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NBT.3590

1 reference

1 May 2018

PubMed ID

27281418

1 reference

1 May 2018